Animal scale-up
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Wajima et al. [63] developed a method for predicting human plasma concentration–time profiles from animal data, building on the earlier Dedrick plot approach [13] but with enhanced flexibility.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [13]
Citations
Cites
Crank, J. (1956) · CERN Document Server (European Organization for Nuclear Research) · Cited by 18,978
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Ni, W.-M. (2011) · Society for Industrial and Applied Mathematics eBooks · doi:10.1137/1.9781611971972 · Cited by 1,064
Biopharmaceutics and Relevant Pharmacokinetics
Wagne, J. G. (1970) · Drug Information Bulletin · doi:10.1177/009286157000400250 · Cited by 616
ADVANCES IN CHEMISTRY SERIES No. 106
(1972) · Analytical Chemistry · doi:10.1021/ac60318a838 · Cited by 513
Quantitative Relations in the Physiological Constitutions of Mammals
Adolph, E. F. (1949) · Science · doi:10.1126/science.109.2841.579 · Cited by 500 · cited 2×
“Inulin clearance 0.77 PAH clearance 0.80 Basal 0 2 consumption 0.734 Endogenous N output 0.72 O 2 consumption by liver slices 0.77 Kidneys weight 0.85 Heart weight 0.98 Liver weight 0.87 Stomach and intestines weight 0.94 Blood weight 0.99 "Abstracted from Adolph ( 23 ).”
BackgroundInfluentialBischoff, K. B., Dedrick, R. L., Zaharko, D. S., & Longstreth, J. A. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600803 · Cited by 480
Self-citationStudies of the enzymatic deamination of cytosine arabinoside—I
Camiener, G. W., & Smith, C. G. (1965) · Biochemical Pharmacology · doi:10.1016/0006-2952(65)90175-9 · Cited by 292
Brodie, B. B., Kurz, H., & Schanker, L. S. (1960) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25859-1 · Cited by 279
Brodie, B. B., Kurz, H., & Schanker, L. S. (1960) · PubMed · Cited by 255
Research works printed but not linked: 3
- K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Prog. Symp. Ser. No. 66 62: 33–45(1966).
- K. B. Bischoff, K. J. Himmelstein, R. L. Dedrick, and D. S. Zaharko. InAdvances in Chemistry Series No. 118, American Chemical Society, Washington, D.C., 1973, pp. 47–64.
- R. L. Dedrick, P. Vantoch, E. A. Gombos, and R. Moore. Kinetics of activated carbon kidney.Trans. Am. Soc. Artif. Int. Organs 13: 236–242 (1967).
Cited by
Items 101–200 of 398
In silico Prediction of Total Human Plasma Clearance
Berellini, G., Waters, N. J., & Lombardo, F. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300155y · Cited by 65
Physiologically Based Pharmacokinetic Model for Digoxin Distribution and Elimination in the Rat
Harrison, L. I., & Gibaldi, M. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660822 · Cited by 66
Pharmacokinetics and Toxicity Testing
Clark, B., Smith, D. A., & Caldwell, J. (1984) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448409044214 · Cited by 65
Andersen, M. E., MacNaughton, M. G., M.A., H. J. C. I., & Paustenbach, D. J. (1987) · American Industrial Hygiene Association Journal · doi:10.1080/15298668791384850 · Cited by 65
Physiologically based pharmacokinetic models for anticancer drugs
Chen, H.-S. G., & Gross, J. F. (1979) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254079 · Cited by 64
“Little work has been done in this area (Dedrick, 1973), and more emphases are required in the future.”
BackgroundMethodInfluentialClearance Mechanism Assignment and Total Clearance Prediction in Human Based upon in Silico Models
Lombardo, F., Obach, R. S., Varma, M. V., Stringer, R., & Berellini, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500436v · Cited by 60
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Ferl, G. Z., Kenanova, V. E., Wu, A. M., & DiStefano, J. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0072 · Cited by 64
“, volume flow rates) can be translated across species using the allometric equation, an empirical power law that relates the biological parameter to body weight (25, 26).”
MethodSugita, O., Sawada, Y., Sugiyama, Y., Iga, T., & Hanano, M. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059263 · Cited by 65
“The muscle volume was assumed to be half of the body weight (24).”
BackgroundInterspecies Pharmacokinetic Scaling, Biological Design and Neoteny
Boxenbaum, H. G., & D'Souza, R. W. (1990) · Advances in Drug Research · doi:10.1016/b978-0-12-013319-2.50006-1 · Cited by 66
Tsuji, A., Nishide, K., Minami, H., Nakashima, E., Terasaki, T., & Yamana, T. (1985) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)09221-9 · Cited by 61
Physiologically Based Pharmacokinetic/Toxicokinetic Modeling
Campbell, J. L., Clewell, R. A., Gentry, P. R., Andersen, M. E., & M.A., H. J. C. I. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-050-2_18 · Cited by 60
A VITALITY-BASED MODEL RELATING STRESSORS AND ENVIRONMENTAL PROPERTIES TO ORGANISM SURVIVAL
Anderson, J. J. (2000) · Ecological Monographs · doi:10.1890/0012-9615(2000)070[0445:avbmrs]2.0.co;2 · Cited by 60
Mahmood, I. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991773320 · Cited by 59
Gupta, P., Kamath, A. V., Park, S., Chiu, H. H., Lutman, J., Maia, M., Tan, M., Xu, M., Swem, L. R., & Deng, R. (2016) · mAbs · doi:10.1080/19420862.2016.1167294 · Cited by 62
“29 QVQ PK data from the single IV dose PK study in cynomolgus monkeys were used to estimate human PK of MHAA4549A using a species-invariant time method.(12) The estimated human serum concentration-time profiles obtained by this method were described well by a linear, 2-compartment model (Fig.”
MethodPhysiologically based pharmacokinetic analyses of simple mixtures.
Krishnan, K., M.A., H. J. C. I., & Andersen, M. E. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s9151 · Cited by 58
Stefanich, E. G., Rae, J., Sukumaran, S., Lutman, J., Lekkerkerker, A., Ouyang, W., Wang, X., Lee, D., Danilenko, D. M., Diehl, L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.031 · Cited by 55
“These exponent values were based on published literature values used in scaling humanized monoclonal antibodies and fusion proteins from cynomolgus monkey data [3,4,22].”
MethodProspective Predictions of Human Pharmacokinetics for Eighteen Compounds
Zhang, T., Heimbach, T., Lin, W., Zhang, J., & He, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24373 · Cited by 56
Tuey, D. B., & Matthews, H. B. (1980) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(80)90355-5 · Cited by 56
Interspecies Correlation of the Pharmacokinetics of Erythromycin, Oleandomycin, and Tylosin
Duthu, G. S. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740907 · Cited by 56
Physiological pharmacokinetics
Bischoff, K. B. (1986) · Bulletin of Mathematical Biology · doi:10.1007/bf02459684 · Cited by 55
Ferl, G. Z., Theil, F., & Wong, H. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1994 · Cited by 54
Harashima, H., Sawada, Y., Sugiyama, Y., Iga, T., & Hanano, M. (1985) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061478 · Cited by 54
“The muscle volume was assumed to be half of the body weight (22).”
BackgroundIwatsubo, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., Yokoi, T., Kamataki, T., & Sugiyama, Y. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36870-3 · Cited by 52
Correlation betweenin vitro andin vivo drug metabolism rate: Oxidation of ethoxybenzamide in rat
Lin, J. H., Hayashi, M., Awazu, S., & Hanano, M. (1978) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060096 · Cited by 53
Weiss, M. (1982) · Journal of Mathematical Biology · doi:10.1007/bf00275690 · Cited by 53
Gold Nanoshells in Biomedical Applications
Erickson, T. A., & Tunnell, J. W. (2009) · Wiley eBooks · doi:10.1002/9783527610419.ntls0150 · Cited by 58
Kagan, L., Abraham, A. K., Harrold, J. M., & Mager, D. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0098-6 · Cited by 50
“This type of relationship works best for drugs eliminated by direct physical processes, such as renal excretion (17).”
Miyamoto, M., Iwasaki, S., Chisaki, I., Nakagawa, S., Amano, N., & Hirabayashi, H. (2017) · Xenobiotica · doi:10.1080/00498254.2016.1265160 · Cited by 54
Time Concepts in Physics, Biology, and Pharmacokinetics
Boxenbaum, H. G. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751107 · Cited by 47
Interspecies Conversion of Kinetically Equivalent Doses1
O’Flaherty, E. J. (1989) · Risk Analysis · doi:10.1111/j.1539-6924.1989.tb01269.x · Cited by 47
Pharmacokinetics and Pharmacodynamics of Biotech Drugs
Meibohm, B., & Derendorf, H. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400105 · Cited by 47
Physiologically Based Pharmacokinetic Modeling
M.A., H. J. C. I., Reddy, M. B., Lavé, T., & Andersen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse065 · Cited by 47
Bungay, P. M., Dedrick, R. L., & Guarino, A. M. (1976) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062827 · Cited by 46
“Scaling processes (1) also should be applicable in the opposite direction, i.”
BackgroundSelf-citationModel-based drug development: application of modeling and simulation in drug development
Kim, T., Shin, S., & Shin, B. S. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0371-3 · Cited by 45
“Similarities in structural, physiological, and biochemical properties among species allow allometric equations that characterize the dependence of biological variables (θ) on body weight (W) (Dedrick 1973; Mordenti 1986): where a and b are drug/process coefficients.”
BackgroundPharmacokinetics of Fluoroquinolones in Experimental Animals
Dalhoff, A., & Bergan, T. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-80364-2_6 · Cited by 45
Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential
D'Souza, R. W., & Boxenbaum, H. G. (1988) · Toxicology and Industrial Health · doi:10.1177/074823378800400202 · Cited by 50
Gargas, M. L., Tyler, T. R., Sweeney, L. M., CORLEY, R. A., Weitz, K., Mast, T. J., Paustenbach, D. J., & Hays, S. M. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8927 · Cited by 44
Physiologically-Based Pharmacokinetic Modeling and Bioactivation of Xenobiotics
M.A., H. J. C. I., & Andersen, M. E. (1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000101 · Cited by 44
Procainamide Disposition in Obesity
Christoff, P. B., Conti, D. R., Naylor, C. W., & Jusko, W. J. (1983) · Annals of Pharmacotherapy · doi:10.1177/106002808301700704 · Cited by 44
Ploeger, B. A., Mensinga, T. T., Sips, A. J. A. M., Meulenbelt, J., & DeJongh, J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007661209921 · Cited by 49
“However, this overestimation is expected to be minimal, since by optimization of only those parameters that have the most influence on the forecast, most of the uncertainty can be is explained (17).”
MethodBassani, D., Parrott, N. J., Manevski, N., & Zhang, J. D. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2348157 · Cited by 45
“Extrapolation from observations in animal studies is used to predict human PK parameters [32,33].”
MethodCisplatin pharmacokinetics: applications of a physiological model
Farris, F. F., Dedrick, R. L., & King, F. G. (1988) · Toxicology Letters · doi:10.1016/0378-4274(88)90024-0 · Cited by 43
Self-citationMethods for Identifying a Default Cross-Species Scaling Factor
Rhomberg, L. R., & Lewandowski, T. A. (2006) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807030600977269 · Cited by 45
“…(ADME) of toxicants and their associated health effects can be drawn together into a single scheme by referring to the concept of physiological time (Dedrick et al. 1970; Dedrick 1973; Boxenbaum 1982, 1983, 1984, 1986; Lindstedt and Calder 1976, 1981; Mordenti 1986; Lindstedt 1987; Travis 1990).”
BackgroundMethodPrediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data
Kawakami, J., Yamamoto, K., Sawada, Y., & Iga, T. (1994) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353329 · Cited by 42
“demonstrated that the plasma concentration profiles of MTX after a single intravenous or intraperitoneal administration in several species could be normalized as a single curve when the plasma concentration divided by the dose per body weight was plotted versus the time divided by the fourth root of body weight (3,4).”
Physiologically based pharmacokinetic model for vinylidene chloride
D'Souza, R. W., & Andersen, M. E. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90159-7 · Cited by 42
Horseshoes, Hand Grenades, and Body-Surface Area–Based Dosing: Aiming for a Target
Egorin, M. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.084 · Cited by 42
Kamath, A. V., Lu, D., Gupta, P., Jin, D., Xiang, H., Wong, A., Leddy, C., Crocker, L., Schaefer, G., Sliwkowski, M. X., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1806-6 · Cited by 41
“The monkey serum concentration–time profiles were transformed to human concentration–time profiles using a species-invariant time method as described previously [11, 12].”
MethodXin, Y., Bai, S., Damico‐Beyer, L. A., Jin, D., Liang, W., Wu, Y., Theil, F., Joshi, A., Lu, Y., Lowe, J. A., III, et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0781-x · Cited by 43
“In support of the Phase Ia study, MNRP1685A PK parameters were predicted based on cynomolgus monkey data (including data from both single dose and multiple dose studies) using the species time-invariantmethod (28) asmonkeys have been shown to be a reliable species for prediction of human PK of typical mAbs (6,7).”
Allometric scaling of pegylated liposomal anticancer drugs
Caron, W. P., M.A., H. J. C. I., Dedrick, R. L., Ramanathan, R. K., Davis, W. L., Yu, N. Y., Tonda, M. E., Schellens, J. H. M., Beijnen, J. H., & Zamboni, W. C. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9213-5 · Cited by 41
“While the MPS has not been evaluated comprehensively in animal models, it is known that canines exhibit marked differences in red blood cells compared to other species [34, 35].”
BackgroundSelf-citationTumor pretargeting for radioimmunodetection and radioimmunotherapy.
Zhu, H. J., Jain, R. K., & Baxter, L. T. (1998) · PubMed · Cited by 41
Lavé, T., Levet‐Trafit, B., Schmitt‐Hoffmann, A. H., Morgenroth, B., Richter, W., & Chou, R. C. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841106 · Cited by 41
Pharmacokinetic/Pharmacodynamic Modeling in Inflammation
Lon, H., Liu, D., & Jusko, W. J. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i4.50 · Cited by 40
Hori, S. S., Lutz, A. M., Paulmurugan, R., & Gambhir, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2904 · Cited by 39
Interspecies Modeling and Prediction of Human Exenatide Pharmacokinetics
Chen, T., Mager, D. E., & Kagan, L. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0917-z · Cited by 38
El-Masri, H. A., Mumtaz, M. M., Choudhary, G., Cibulas, W., & Rosa, C. T. D. (2002) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00130 · Cited by 39
Prediction of aztreonam pharmacokinetics in humans based on data from animals
Swabb, E. A., & BONNER, D. P. (1983) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061865 · Cited by 39
“where a, b, c, and d are semiempirical coefficients and exponents depending on the particular drug being studied ( 1-4 ).”
BackgroundPhysiological pharmacokinetics and cancer risk assessment
Andersen, M. E., Krewski, D. R., & Withey, J. R. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90025-5 · Cited by 39
Brouwer, K. L. R., & Thurman, R. G. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_10 · Cited by 38
Pharmacokinetics of Liquiritigenin in Mice, Rats, Rabbits, and Dogs, and Animal Scale-Up
Kang, H. E., Jung, H. Y., Cho, Y. K., Kim, S. H., Sohn, S. I., Baek, S. R., & Lee, M. G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21702 · Cited by 38
“Interspecies scaling of the CL of drugs appeared to be relatively successful for drugs which are mainly excreted via the kidney (such as physical process).(25,26) However, the scaling of the CL among species was less successful if drug metabolism was the primary route for elimination (such as chemical process),(25,27)…”
BackgroundJain, R. K. (1994) · Advances in chemical engineering · doi:10.1016/s0065-2377(08)60214-8 · Cited by 41
Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area?
Calabrese, E. J., Beck, B. D., & Chappell, W. R. (1992) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(92)90048-e · Cited by 37
Physiologic Pharmacokinetic Models: Relevance, Experience, and Future Trends
Rowland, M. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409015057 · Cited by 40
The Integrated Use of Alternative Approaches for Predicting Toxic Hazard
Barratt, M. D., Castell, J. V., Chamberlain, M. P., Combes, R. D., Dearden, J. C., helen, F. J., Gerner, I., Giuliani, A., Gray, T. J. B., Livingstone, D. J., et al. (1995) · Alternatives to Laboratory Animals · doi:10.1177/026119299502300315 · Cited by 37
Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance from Animals to Humans
Mahmood, I. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001214 · Cited by 36
Oitate, M., Nakayama, S., Ito, T., Kurihara, A., Okudaira, N., & Izumi, T. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-sh-059 · Cited by 35
Ferl, G. Z., Reyes, A. E., Sun, L. L., Cheu, M., Oldendorp, A., Ramanujan, S., & Stefanich, E. G. (2018) · Clinical and Translational Science · doi:10.1111/cts.12535 · Cited by 36
Huang, C., Zheng, M., Yang, Z., Rodrigues, A. D., & Marathe, P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9411-4 · Cited by 36
“The concept of allometric scaling is based on the assumption that the anatomical, physiological, and biochemical variables of mammals can be scaled across species based on the body weight (24,25).”
BackgroundMethodBioavailability and Pharmacokinetic Analysis of Drug Responding Systems
Smolen, V. F. (1978) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.18.040178.002431 · Cited by 35
Zaleplon pharmacokinetics and absolute bioavailability
Rosen, A. S., Fournié, P., Darwish, M., Danjou, P., & Troy, S. M. (1999) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199904)20:3<171::aid-bdd169>3.0.co;2-k · Cited by 83
Dose–response modeling in reproductive toxicology in the systems biology era
Andersen, M. E., Thomas, R. S., Gaido, K. W., & Conolly, R. B. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2004.12.004 · Cited by 38
Vaughan, D. P., & Hope, I. (1979) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059739 · Cited by 34
“c o Io dt = FoDorK21 CV, oF (K2o-~ K21)[ V1Klo-+Vl ~ KlJgl~ -1 (18) j=2 (Kj~ +K/o)J”
BackgroundInfluentialPrediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data
Li, C., Zhang, C., Deng, R., Leipold, D. D., Li, D., Latifi, B., Gao, Y., Zhang, C., Li, Z., Miles, D., et al. (2019) · Clinical and Translational Science · doi:10.1111/cts.12649 · Cited by 34
He, H., Zhao, W., Qin, N., & Duan, X. (2024) · Toxics · doi:10.3390/toxics12060433 · Cited by 35
“It was not until 1973 that Dedrick introduced the concept of scaling up, which opened animal–human extrapolation [6].”
BackgroundGentry, P. R., M.A., H. J. C. I., Clewell, R. A., Campbell, J. L., Landingham, C. B. V., & Shipp, A. M. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.599366 · Cited by 33
“PPAR receptors, and according to DeLuca et al. (2000), agents that have some affinity”
MethodTissue distribution kinetics of tetraethylammonium ion in the rat
Mintun, M. A., Himmelstein, K. J., Schroder, R. L., Gibaldi, M., & Shen, D. D. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059385 · Cited by 32
Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys
Furukawa, T. Y., Naritomi, Y., Tetsuka, K., Nakamori, F., Moriguchi, H., Yamano, K., Terashita, S., Tabata, K., & Teramura, T. (2013) · Xenobiotica · doi:10.3109/00498254.2013.828362 · Cited by 33
“7 mL/min/kg) were based on reported values (Davies & Morris, 1993; Sawada, 1985).”
MethodInfluentialKolanjiyil, A. V., & Kleinstreuer, C. (2013) · Journal of Biomechanical Engineering · doi:10.1115/1.4025333 · Cited by 31
Sugahara, S.-I., Okuno, S., Yano, T., Hamana, H., & Inoue, K. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.535 · Cited by 31
A semiparametric approach to physiological flow models
Verotta, D., Sheiner, L. B., Ebling, W. F., & Stanski, D. R. (1989) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061458 · Cited by 33
“Taking our clue from Eq. (7) and from Dedrick ( 23 ) for the perfusion-limited case, one can use F'(t) instead of F(t) where”
MethodEffect of Lipophilicity on the in vivo localization of radiolabelled spiperone analogues
Moerlein, S. M., Laufer, P., & Stöcklin, G. (1985) · International Journal of Nuclear Medicine and Biology · doi:10.1016/s0047-0740(85)80003-6 · Cited by 30
Mahmood (2002) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2002.19.1.49 · Cited by 29
Fuse, E., Kobayashi, T., Inaba, M., & Sugiyama, Y. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90024-1 · Cited by 29
Inaba, M., Tashiro, T., Kobayashi, T., Fujimoto, S., Sakurai, Y., Maruo, K., Ohnishi, Y., Ueyama, Y., & Nomura, T. (1986) · PubMed · Cited by 29
Mass Transport in Tumors: Characterization and Applications to Chemotherapy
Jain, R. K., Weissbrod, J. M., & Wel, J. (1980) · Advances in cancer research · doi:10.1016/s0065-230x(08)60672-7 · Cited by 32
Randomness, Time Scales, and the Evolution of Biological Communities
LEVANDOWSKY, M., & White, B. S. (1977) · Springer eBooks · doi:10.1007/978-1-4615-6953-4_2 · Cited by 34
Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data
Kurihara, A., Naganuma, H., Hisaoka, M., Tokiwa, H., & Kawahara, Y. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1810 · Cited by 29
Technologies for Measuring Pharmacokinetic Profiles
Heller, A. A., Lockwood, S. Y., Janes, T., & Spence, D. M. (2018) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061417-125611 · Cited by 29
Allometric analysis of doxycycline pharmacokinetic parameters
Riond, J. ‐., & Riviere, J. E. (1990) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1990.tb00795.x · Cited by 28
The anti-nociceptive efficacy of low dose intramuscular xylazine in lambs
Grant, C. M., & Upton, R. N. (2001) · Research in Veterinary Science · doi:10.1053/rvsc.2000.0439 · Cited by 28
A Statistical Model for Species Extrapolation Using Categorical Response Data
Hertzberg, R. C., & Miller, M. (1985) · Toxicology and Industrial Health · doi:10.1177/074823378500100405 · Cited by 28
Estimation of Human Drug Clearance Using Multiexponential Techniques
Goteti, K., Brassil, P. J., Good, S. S., & Garner, C. E. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008320369 · Cited by 28
“Simple allometric (SA) scaling is a technique in which the log transform of clearance from preclinical species is correlated with body weight to predict clearance in humans.(3,4) Because of the simplicity of the technique, it is one of the most popular methods for predicting human clearance from clearances measured in…”
MethodKenyon, E. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-050-2_19 · Cited by 30
Explorations of Molecular Structure-Property Relationships
Seybold, P. G. (1999) · SAR and QSAR in environmental research · doi:10.1080/10629369908039171 · Cited by 27
Inaba, M., Tashiro, T., Kobayashi, T., Sakurai, Y., Maruo, K., Ohnishi, Y., Ueyama, Y., & Nomura, T. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01621.x · Cited by 27
Can Allometric Interspecies Scaling be Used to Predict Human Kinetics?
Campbell, D. B. (1994) · Drug Information Journal · doi:10.1177/009286159402800130 · Cited by 26
A STEADY-STATE FUGACITY-BASED PHARMACOKINETIC MODEL WITH SIMULTANEOUS MULTIPLE EXPOSURE ROUTES
Paterson, S., & Mackay, D. (1987) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620060508 · Cited by 25
Pharmacokinetic scaling of bisphenol A by species-invariant time methods
Cho, C. Y., Shin, B. S., Jung, J. H., Kim, D.-H., Lee, K. C., Han, S.-Y., Kim, H. S., Lee, B. M., & Yoo, S. D. (2002) · Xenobiotica · doi:10.1080/00498250210163315 · Cited by 24
Kamath, A. V., Lu, D., Gupta, P., Jin, D., Xin, Y., Brady, A., Stéphan, J.-P., Li, H., Tien, J., Qing, J., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1807-5 · Cited by 25
“Pharmacokinetics from the single IV dose PK study in cynomolgus monkeys were used to estimate human pharmacokinetics using a species-invariant time method [13].”
MethodA pharmacokinetic model of styrene inhalation with the fugacity approach
Paterson, S., & Mackay, D. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90279-6 · Cited by 23
Interspecies Scaling of Anesthetic Potency
Travis, C. C., & Bowers, J. C. (1991) · Toxicology and Industrial Health · doi:10.1177/074823379100700402 · Cited by 23
Metadata
- Authors
- Dedrick, R. L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Dedrick, Robert L.
- Venue
- Journal of Pharmacokinetics and Biopharmaceutics
- Published
- 1973-10
- Volume
- 1
- Issue
- 5
- Pages
- 435-461
- ISSN
- 0090-466X (ISSN-L)
- OpenAlex
- W2042365192
- Cited by
- 397
- References
- 52
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 11 · 2018: 7 · 2017: 2 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 15 · 2012: 14
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Pharmacokinetics and Biopharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- drug distribution, blood flow, tissue binding, renal clearance, drug metabolism, species differences, methotrexate, thiopental, cytarabine
- MeSH terms
- Animals, Biological Transport, Biotransformation, Body Weight, Chlorides, Cytarabine, Dialysis, Diffusion, Pharmaceutical Preparations, Humans, Kinetics, Mammals, Methotrexate, Models, Biological, Organ Specificity, Pharmacology, Species Specificity, Thermodynamics, Thiopental, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.